Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Announces Integration of Therimmune; VP to Step Down

NEW YORK (GenomeWeb News) Oct. 1 - Gene Logic said today that it has reorganized its information services and contract study services business following its acquisition, last April of TherImmune Research.


As part of the reorganization, the company said it will no longer use the TherImmune Research Corporation name,a nd that all service offerings to pharmaceutical and biotechnology companies will be marketed under the Gene Logic name.


As part of this integration, Steve Trevisan, executive vice president and a director of the company, will step down, but will continue "in an advisory capacity" until the end of the year.


Trevisan was formerly president and CEO of TherImmune Research, and came on board at Gene Logic when the company  acquired TherImmune in April of this year.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.